Loading organizations...
Loading organizations...
Developer of protein-conjugated medicines for cancer therapy.
Conjustar has raised $27.7M across 3 funding rounds.
Conjustar has raised $27.7M in total across 3 funding rounds.
Conjustar has raised $27.7M in total across 3 funding rounds.
Conjustar's investors include Fosun Pharma, Shenzhen Qianhai Liyuan, Zhuhai Gree Chuantou, Fu Jian Capital, Ning Bo Xin Huan, Su Zhou Tai Hao Chuang Tou, Rehabilitation Capital.
Conjustar has raised $27.7M across 3 funding rounds. Most recently, it raised $12.5M Pre-Series A in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 30, 2024 | $12.5M Pre-Series A | Fosun Pharma | Shenzhen Qianhai Liyuan, Zhuhai Gree Chuantou |
| Feb 23, 2023 | $8.0M Other Equity | Fu Jian Capital | Ning Bo Xin Huan, Su Zhou Tai Hao Chuang Tou |
| Feb 21, 2022 | $7.2M Seed | Rehabilitation Capital |